Oruka Therapeutics, Inc. (ORKA) — Cash Flow-to-Debt Ratio
Oruka Therapeutics, Inc. (ORKA) has a Cash Flow-to-Debt Ratio of -0.96x as of September 2025, meaning its operating cash flow of $-21.60 Million could theoretically repay -1% of its total liabilities ($22.46 Million) in one year. Explore investment intensity of Oruka Therapeutics, Inc. to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oruka Therapeutics, Inc. Cash Flow-to-Debt Ratio (2005–2024)
Historical debt coverage capacity for Oruka Therapeutics, Inc. across 19 annual periods. Also explore how large is Oruka Therapeutics, Inc.'s balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Oruka Therapeutics, Inc. (2005–2024)
Year-by-year debt coverage analysis for Oruka Therapeutics, Inc.. For market capitalisation and broader financial context, see ORKA stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.19x | $-57.84 Million | $13.80 Million | ▲ +45.8% |
| 2022 | -7.73x | $-10.91 Million | $1.41 Million | ▼ -59.9% |
| 2021 | -4.83x | $-18.76 Million | $3.88 Million | ▼ -144.6% |
| 2020 | -1.98x | $-7.72 Million | $3.91 Million | ▲ +61.9% |
| 2019 | -5.18x | $-4.80 Million | $926.00K | ▲ +50.1% |
| 2018 | -10.40x | $-8.24 Million | $793.00K | ▼ -24.4% |
| 2017 | -8.36x | $-17.47 Million | $2.09 Million | ▼ -35.8% |
| 2016 | -6.15x | $-14.99 Million | $2.44 Million | ▲ +12.1% |
| 2015 | -7.00x | $-10.53 Million | $1.50 Million | ▼ -3.6% |
| 2014 | -6.76x | $-9.41 Million | $1.39 Million | ▼ -92.2% |
| 2013 | -3.52x | $-5.29 Million | $1.50 Million | ▲ +73.7% |
| 2012 | -13.37x | $-4.08 Million | $305.00K | ▼ -47.9% |
| 2011 | -9.04x | $-6.96 Million | $770.00K | ▼ -50.4% |
| 2010 | -6.01x | $-8.32 Million | $1.39 Million | ▲ +71.8% |
| 2009 | -21.29x | $-41.73 Million | $1.96 Million | ▼ -1796.4% |
| 2008 | -1.12x | $-18.40 Million | $16.39 Million | ▼ -29.5% |
| 2007 | -0.87x | $-45.96 Million | $53.02 Million | ▼ -167.9% |
| 2006 | -0.32x | $-37.06 Million | $114.56 Million | ▲ +71.9% |
| 2005 | -1.15x | $-59.03 Million | $51.28 Million | — |